Identifying and collaborating with trusted social media voices to share HIV information with the communities that need it
New documentary considers the last mile to ‘Ending HIV in America’
A upcoming PBS documentary, “Ending HIV in America,” recounts the history of the AIDS epidemic and looks at how far HIV prevention and treatment efforts have come.
PrEP use data comes to life in new graphics
AIDSVu has released a new set of infographics featuring the first-ever publicly available state-level data and regional maps on PrEP use by race and ethnicity, from 2012 to 2021.
Campaña bilingual para PrEP en Chicago
A bilingual campaign in Spanish and English promoting HIV prevention via medicine
Virtual CROI 2022: The dapivirine ring vs. the FDA
This PrEP method is still a desirable option in the U.S. for cisgender women
Briefly May+Jun 2022
Cabenuva long-acting injectable no longer requires a month of oral lead-in medication
A clinic on wheels serves people who inject drugs
As health care providers move further into telehealth services, clinics on wheels rolled out in five cities to serve people who inject drugs who are living with or are at risk for HIV.
As long-acting treatment and prevention begins to enter communities, we must move toward dismantling systemic racism
NYC’s Daskalakis named as CDC HIV prevention chief
Known for his activism, an NYC public health doctor will play a national role
HIV prevention drugs now available in California without prescription
California becomes first U.S. allowing pharmacies to dispense PrEP and PEP without a prescription
Pickett Fences: Love the One You’re With – Sex and Pleasure in the time of COVID-19
So HOW IN THE HELL do we talk about sex and pleasure now?
PrEP battles for the vagina
Research for cisgender women and adolescent girls is underway to help determine vaginal protection with Descovy for PrEP
Pregnancy and dolutegravir; AIDS Quilt finds a new home; survey on women living with HIV; and more
Challenges accessing PrEP for HIV prevention in England
Access to PrEP is uneven and problematic, and not just in the U.S.
FDA approves Descovy for PrEP; Delstrigo and Pifeltro approved for switch treatment; Bictegravir, dolutegravir and Tybost for children; and more.
Dolutegravir during pregnancy
Based on new data, the World Health Organization (WHO) recommended dolutegravir as a preferred HIV drug for all populations living with HIV, including pregnant women and those wanting to conceive.
HIV meds just four days a week?
And other conference highlights including new long-acting drug GS-6207; PrEP on demand; HIV treatment = prevention.
Building blocks for a healthy life
Building blocks for a healthy life, with insights from a nurse educator
Partners to the End
Public-private partnerships for a vaccine sustain a global response to help end HIV
Biktarvy and antacids. Descovy FDA hearing. Updated guidelines for transgender individuals. Biktarvy and kids. PrEP4Love. Michael Johnson freed.
Monthly injectable HIV med on the way; HIV pharma sued over pricing practices; Australian PrEP advocate talks about his new HIV status; tenofovir class action lawsuits
Looking back, looking ahead
After more than 30 years of treating young people living with HIV, Dr. Lisa Henry-Reid reflects on what more still needs to be done
The Cutting Edge
Innovations in prevention and care can be found anywhere—the author highlights three examples
Benefits of Safer Drug Consumption Spaces
Why Safe Consumption Spaces for people who use drugs would benefit society.
The Science of U=U
People on treatment with an undetectable viral load do not transmit HIV—here's how.
Anti-alcohol drug, gay journalist grant, life insurance for people with HIV, Grindr & PrEP
Look At What The Stork Delivered
With the help of PrEP, Shannon Weber helps positive people have a baby—safely
How Do I Pay for PrEP?
Insurance coverage and other access hurdles can be overcome, but it might take work